Sanofi India to Sell 1.5 Lakh Sq Ft Mumbai Headquarters

Sanofi's Indian arm is set to sell its 150,000 sq ft headquarters in Mumbai’s Powai locality. This move is part of a broader strategy to relocate and expand its operations, including shifting its Sanofi Consumer Healthcare division to a newly leased office in the Vikhroli suburb.

Key Details:

- Location: Powai, Mumbai.

- Size: 150,000 sq ft.

- Expected Sale Value: Approximately Rs 250 crore.

- New Location: Sanofi Consumer Healthcare division moving to Vikhroli.

- Lease Agreement: Long-term lease with initial occupancy from June 2024.

Background:

- Acquisition: The Powai property was acquired from L&T Realty in 2013 and became Sanofi’s headquarters in 2015.

- Relocation Plan: The Vikhroli office lease is part of a strategic plan to consolidate operations and improve infrastructure.

Strategic Move:

Sanofi’s decision to sell the Powai property aligns with its asset monetization strategy and growth plans for its divisions. The new Vikhroli office is expected to accommodate the Sanofi Consumer Healthcare division, with additional space leased for other operations. The Powai asset sale is anticipated to fetch around Rs 250 crore based on current market rates.

Demerger:

- Consumer Health Business: In May 2023, Sanofi's board decided to demerge its consumer health business into a separate entity. This move, approved by shareholders in December and sanctioned by the National Company Law Tribunal, Mumbai, in May 2024, led to the formation of Sanofi Consumer Healthcare Ltd.

- New Entity Operations: The demerged entity will operate from the newly leased Vikhroli office, which is currently being fitted out.

Market Context:

- Importance of Indian Market: Sanofi India's Ma